Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 346

1.

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.

Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Sen HT, van der Meulen MC, Weinstein RS, Whyte M; American Society for Bone and Mineral Research.

J Bone Miner Res. 2010 Nov;25(11):2267-94. doi: 10.1002/jbmr.253. Erratum in: J Bone Miner Res. 2011 Aug;26(8):1987.

2.

Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP.

J Bone Miner Res. 2014 Jan;29(1):1-23. doi: 10.1002/jbmr.1998. Epub 2013 Oct 1. Review.

3.

Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E; American Society for Bone and Mineral Research.

J Bone Miner Res. 2007 Oct;22(10):1479-91.

4.

Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.

Nieves JW, Cosman F.

Curr Osteoporos Rep. 2010 Mar;8(1):34-9. doi: 10.1007/s11914-010-0007-2. Review.

PMID:
20425089
5.

Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series.

Sasaki S, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y.

J Bone Miner Metab. 2012 Sep;30(5):561-7. doi: 10.1007/s00774-012-0358-0. Epub 2012 May 19.

PMID:
22610061
6.

Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures.

Napoli N, Jin J, Peters K, Wustrack R, Burch S, Chau A, Cauley J, Ensrud K, Kelly M, Black DM.

J Clin Endocrinol Metab. 2012 Jul;97(7):2414-22. doi: 10.1210/jc.2011-3256. Epub 2012 Apr 30.

7.

Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.

Lee JK.

Int J Rheum Dis. 2009 Jul;12(2):149-54. doi: 10.1111/j.1756-185X.2009.01396.x.

PMID:
20374333
8.

Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features.

Giusti A, Hamdy NA, Dekkers OM, Ramautar SR, Dijkstra S, Papapoulos SE.

Bone. 2011 May 1;48(5):966-71. doi: 10.1016/j.bone.2010.12.033. Epub 2010 Dec 31.

PMID:
21195812
9.

Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report.

Bissonnette L, April PM, Dumais R, Boire G, Roux S.

Bone. 2013 Oct;56(2):406-9. doi: 10.1016/j.bone.2013.07.012. Epub 2013 Jul 17.

PMID:
23871749
10.

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC; Fracture Intervention Trial Steering Committee; HORIZON Pivotal Fracture Trial Steering Committee.

N Engl J Med. 2010 May 13;362(19):1761-71. doi: 10.1056/NEJMoa1001086. Epub 2010 Mar 24.

11.

Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.

Kim SY, Schneeweiss S, Katz JN, Levin R, Solomon DH.

J Bone Miner Res. 2011 May;26(5):993-1001. doi: 10.1002/jbmr.288.

12.

Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.

Chang ST, Tenforde AS, Grimsrud CD, O'Ryan FS, Gonzalez JR, Baer DM, Chandra M, Lo JC.

Bone. 2012 Sep;51(3):524-7. doi: 10.1016/j.bone.2012.05.010. Epub 2012 May 23.

PMID:
22634175
13.

Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.

Thompson RN, Phillips JR, McCauley SH, Elliott JR, Moran CG.

J Bone Joint Surg Br. 2012 Mar;94(3):385-90. doi: 10.1302/0301-620X.94B3.27999.

PMID:
22371548
14.

Atypical subtrochanteric fractures, bisphosphonates, blinded radiological review.

Warren C, Gilchrist N, Coates M, Frampton C, Helmore J, McKie J, Hooper G.

ANZ J Surg. 2012 Dec;82(12):908-12. doi: 10.1111/j.1445-2197.2012.06199.x. Epub 2012 Sep 3.

PMID:
22943522
15.

Incidence and demography of femur fractures with and without atypical features.

Feldstein AC, Black D, Perrin N, Rosales AG, Friess D, Boardman D, Dell R, Santora A, Chandler JM, Rix MM, Orwoll E.

J Bone Miner Res. 2012 May;27(5):977-86. doi: 10.1002/jbmr.1550.

16.

Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report.

Niikura T, Lee SY, Sakai Y, Kuroda R, Kurosaka M.

J Med Case Rep. 2015 May 6;9:103. doi: 10.1186/s13256-015-0590-z.

17.

The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.

Weil YA, Rivkin G, Safran O, Liebergall M, Foldes AJ.

J Trauma. 2011 Jul;71(1):186-90. doi: 10.1097/TA.0b013e31821957e3.

PMID:
21610533
18.

Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis.

Gedmintas L, Solomon DH, Kim SC.

J Bone Miner Res. 2013 Aug;28(8):1729-37. doi: 10.1002/jbmr.1893. Review.

19.

Incidence of atypical nontraumatic diaphyseal fractures of the femur.

Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM.

J Bone Miner Res. 2012 Dec;27(12):2544-50. doi: 10.1002/jbmr.1719.

20.

Predictors of atypical femoral fractures during long term bisphosphonate therapy: a case series & review of literature.

Bhadada SK, Sridhar S, Muthukrishnan J, Mithal A, Sharma DC, Bhansali A, Dhiman V.

Indian J Med Res. 2014 Jul;140(1):46-54. Review.

Items per page

Supplemental Content

Write to the Help Desk